Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Evolent Health Inc shares valued at $731,790 were sold by McCarthy Daniel Joseph on Aug 22 ’24. At $30.89 per share, McCarthy Daniel Joseph sold 23,693 shares. The insider’s holdings dropped to 198,809 shares worth approximately $4.92 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, McCarthy Daniel Joseph sold 10,469 shares, netting a total of over 339,008 in proceeds. Following the sale of shares at $32.38 each, the insider now holds 188,340 shares.
Before that, Weinberg Jonathan had sold 42,140 shares from its account. In a trade valued at $1,314,706, the General Counsel traded Evolent Health Inc shares for $31.20 each. Upon closing the transaction, the insider’s holdings decreased to 42,140 shares, worth approximately $4.14 million.
As published in their initiating research note from KeyBanc Capital Markets on October 11, 2024, Evolent Health Inc [EVH] has been an Overweight and the price target has been revised to $35. Analysts at Truist upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early August. As of April 22, 2024, Citigroup has initiated its “Buy” rating for EVH. Earlier on March 01, 2024, Oppenheimer initiated its rating. Their recommendation was “an Outperform” for EVH stock.
Analyzing EVH Stock Performance
During the last five days, there has been a surge of approximately 2.61%. Over the course of the year, Evolent Health Inc shares have dropped approximately -25.01%. Shares of the company reached a 52-week high of $35.00 on 03/04/24 and a 52-week low of $17.98 on 07/01/24. A 50-day SMA is recorded $27.33, while a 200-day SMA reached $27.00. Nevertheless, trading volume fell to 2.04 million shares from 1.03 million shares the previous day.
Support And Resistance Levels for Evolent Health Inc (EVH)
According to the 24-hour chart, there is a support level at 24.03, which, if violated, would cause prices to drop to 23.30. In the upper region, resistance lies at 25.36. The next price resistance is at 25.96. RSI (Relative Strength Index) is 48.89 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.41, which suggests the price will decrease in the coming days. Percent R is at 15.38%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
